Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study

CONCLUSIONS: Monitoring the urinary levels of a cancer-associated biomarker panel enabled the discrimination of patients who did not respond to intravesical BCG therapy. With further study, the multiplex OncuriaTM test may be applicable for the clinical evaluation of bladder cancer patients considering intravesical BCG treatment.PMID:34511488 | DOI:10.3233/CBM-210221

Source: Cancer Biomarkers - September 13, 2021 Category: Cancer & Oncology Authors: Kaoru Murakami Ashish M Kamat Yunfeng Dai Ian Pagano Runpu Chen Yijun Sun Amit Gupta Steve Goodison Charles J Rosser Hideki Furuya Source Type: research